» Articles » PMID: 39458462

Unveiling Lipidomic Alterations in Metabolic Syndrome: A Study of Plasma, Liver, and Adipose Tissues in a Dietary-Induced Rat Model

Overview
Journal Nutrients
Date 2024 Oct 26
PMID 39458462
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic syndrome (MetS) is a complex condition characterized by fat accumulation, dyslipidemia, impaired glucose control and hypertension. In this study, rats were fed a high-fat high-fructose (HFF) diet in order to develop MetS. After ten weeks, the dietary-induced MetS was confirmed by higher body fat percentage, lower HDL-cholesterol and increased blood pressure in the HFF-fed rats compared to the normal-fed control animals. However, the effect of MetS development on the lipidomic signature of the dietary-challenged rats remains to be investigated. To reveal the contribution of specific lipids to the development of MetS, the lipid profiling of rat tissues particularly susceptible to MetS was performed using untargeted UHPLC-QTOF-MS/MS lipidomic analysis. A total of 37 lipid species (mainly phospholipids, triglycerides, sphingolipids, cholesterol esters, and diglycerides) in plasma, 43 lipid species in liver, and 11 lipid species in adipose tissue were identified as dysregulated between the control and MetS groups. Changes in the lipid signature of selected tissues additionally revealed systemic changes in the dietary-induced rat model of MetS.

References
1.
Fahed G, Aoun L, Zerdan M, Allam S, Zerdan M, Bouferraa Y . Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022; 23(2). PMC: 8775991. DOI: 10.3390/ijms23020786. View

2.
Kamboj P, Sarkar S, Gupta S, Bisht N, Kumari D, Alam M . Methanolic Extract of Lindl. Prevents High-Fat High-Fructose-Induced Fatty Liver in Rats: Understanding the Molecular Mechanism Through Untargeted Metabolomics Study. Front Pharmacol. 2021; 12:653872. PMC: 8082144. DOI: 10.3389/fphar.2021.653872. View

3.
Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, Raciti G . Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications. Int J Mol Sci. 2019; 20(9). PMC: 6539070. DOI: 10.3390/ijms20092358. View

4.
La Russa D, Giordano F, Marrone A, Parafati M, Janda E, Pellegrino D . Oxidative Imbalance and Kidney Damage in Cafeteria Diet-Induced Rat Model of Metabolic Syndrome: Effect of Bergamot Polyphenolic Fraction. Antioxidants (Basel). 2019; 8(3). PMC: 6466566. DOI: 10.3390/antiox8030066. View

5.
Bacle A, Kadri L, Khoury S, Ferru-Clement R, Faivre J, Cognard C . A comprehensive study of phospholipid fatty acid rearrangements in metabolic syndrome: correlations with organ dysfunction. Dis Model Mech. 2020; 13(6). PMC: 7328154. DOI: 10.1242/dmm.043927. View